Donor Stem-Cell Transplant Best For Acute Myeloid Leukemia
People in all risk groups, but especially those with poor and intermediate risk of survival, benefit most, researchers say
Posted June 9, 2009
Dr. Barton A Kamen, chief medical officer at the Leukemia & Lymphoma Society, thinks this study will help doctors develop treatment plans.
"If I find out I have acute myeloid leukemia, I want them to do my cytogenetics and tailor the therapy to fit me and my disease," Kamen said. "This article confirms that."
More information
For more information on acute myeloid leukemia, visit the American Cancer Society.
advertisement
